The PCPT has shown finasteride to be an effective chemopreventive agent in low-grade prostate cancer. Enthusiasm for its widespread use has been tempered by the reported increase in high-grade cancers ...

Four thousand four hundred forty men in the finasteride group of the PCPT underwent prostate biopsy, had at least one PSA and a digital rectal exam (DRE) during the year before biopsy, had at least ...

For many men, the gradual thinning of hair is about more than just their appearance. Finasteride, a drug widely prescribed for the treatment of male pattern baldness, has been used effectively for ...

The 24.8% relative risk reduction in prostate cancer seen in the finasteride arm prompted the early termination of the study on February 21, 2003, 15 months before its anticipated completion. While ...